| |
---|
| Detailed Price Information Link |
BACTERIA | How to read the following data (Example) |
Name: | Legionella gratiana Bornstein et al. 1991 |
DSM No.: | 21233, Type strain dsm-21233 dsm21233 dsm 21233 Legionella gratiana |
Strain designation: | Lyon 8420412 |
Other collection no. or WDCM no.: | CIP 105267,NCTC 12388,ATCC 49413,CCUG 44894 |
Isolated from: | thermal spa |
Country: | France |
Date of sampling: | before 03.03.2008 |
Nagoya Protocol Restrictions: | France requires a benefit-sharing declaration for French genetic resources at the time of utilization, i.e., conducting research. France considers access to genetic resources when utilization begins and not when the initial collection of the material took place and applies to material both in-situ and ex-situ and users within and outside of France.
To comply with French law, you, the user need to make a Declaration regarding access to genetic resources and benefit-sharing arising from your non-commercial utilisation of genetic resources. The steps are the following:
1. File a declaration via the CERFA form n. 15786 (https://www.formulaires.service-public.fr/gf/getAnnexe.do?cerfaAnnexe=1&cerfaFormulaire=15786*02) or by electronic procedure (https://www.demarches-simplifiees.fr/commencer/apa-declaration-pmorale)
2. Await approval by the Ministry for the Ecological Transition, the competent national authority
3. Respond to any requests for more information from the competent national authority
4. Receive an acknowledgment of receipt by the competent national authority certifying the prior informed consent (PIC) and establishment of mutually agreed terms (MAT) regarding benefit-sharing. This procedure shall not exceed 2 months.
For more information about this topic please see the Access and Benefit-Sharing Clearing House: https://absch.cbd.int/en/countries/FR
For more information about the commercial use of this genetic resources please contact: justiziariat@dsmz.de |
History: | <- CIP; Lyon 8420412 {2008} <- CDC <- N. Bornstein |
Genbank accession numbers: | 16S rRNA gene: Z49725 |
Cultivation conditions: | Medium 585 , microaerophilic; needs high humidity, 37°C
For the solubilization of the freeze-dried pellet any standard liquid medium (e.g. M1, M220; M92; M215) can be used
Incubation time: 2-3 days
Complete DSMZ Media List |
Summary and additional information: | <- CIP; Lyon 8420412 {2008} <- CDC <- N. Bornstein. Thermal spa; France. Type strain. Taxonomy/description (5383). Sequence accession no. 16S rRNA gene: Z49725. (Medium 585, 37°C, microaerophilic; needs high humidity). For the solubilization of the freeze-dried pellet any standard liquid medium (e.g. M1, M220; M92; M215) can be used. |
Literature: | 5383 |
Risk group: | 1 (+) (classification according to German TRBA) |
Supplied as: | Delivery form | | Prices | | Freeze Dried | | 100,- € | Active culture on request | | 240,- € | DNA | | 150,- € | | Price Category for this culture: 1 |
Freight and handling charges will be added. See price list. |
Other cultures: | All DSMZ cultures of the species |
| Print data sheet |